cbdMD Expands Product Offering and Nationwide Footprint with Major Retail Partner GNCBusiness Wire • 03/03/22
cbdMD Requests the Food and Drug Administration (FDA) Remove the Drug Exclusion for CBD and Review cbdMD's Extensive Safety SubmissionBusiness Wire • 02/22/22
cbdMD Becomes First American CBD Brand to Receive Validation by the United Kingdom Food Standards AgencyBusiness Wire • 02/17/22
cbdMD's (YCBD) CEO Marty Sumichrast on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 02/11/22
cbdMD Completes Third Full Year Results; Total Brands Sales of $118.7 Million Exceeds Initial Earn Out TargetBusiness Wire • 02/10/22
cbdMD Becomes The First CBD Company With NSF International's Certified For Sport CertificationBenzinga • 02/07/22
cbdMD Becomes the First CBD Company to Earn Prestigious NSF International's Certified for Sport® CertificationBusiness Wire • 02/07/22
cbdMD, Inc. To Host Conference Call To Discuss December 31, 2021, First Quarter ResultsBusiness Wire • 01/24/22
cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 12/18/21
Due To Technical Difficulties, cbdMD, Inc. Moves Conference Call To Discuss September 30, 2021, Fourth Quarter and Fiscal Year Results To December 17, 2021 at 4:15 pm ESTBusiness Wire • 12/16/21
cbdMD Therapeutics Announces Human Clinical Study In Collaboration With the University of South CarolinaBusiness Wire • 12/03/21
cbdMD, Inc. To Host Conference Call To Discuss September 30, 2021 Fourth Quarter and Fiscal Year ResultsBusiness Wire • 12/02/21